This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Oophorectomy if no personal history of breast cancer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Risk-reducing oophorectomy for women with no personal history of breast cancer

  • risk-reducing bilateral oophorectomy is appropriate only for a small proportion of women who are from high-risk families and should be managed by a multidisciplinary team
  • women considering risk-reducing bilateral oophorectomy should be informed of possible psychosocial and sexual consequences of the procedure and have the opportunity to discuss these issues
  • women not at high risk who raise the possibility of risk-reducing bilateral oophorectomy should be offered appropriate information, and if seriously considering this option should be offered referral to the team that deals with women at high risk
  • women undergoing bilateral risk-reducing oophorectomy should have their fallopian tubes removed as well

Breast cancer risk category

Near population risk

Moderate risk

High Risk *

Lifetime risk from age 20

Less than 17%

Greater than 17% but less than 30%

30% or greater

Risk between ages 40 and 50

Less than 3%

3-8%

Greater than 8%

*This group includes known BRCA1, BRCA2 and TP53 mutations and rare conditions that carry an increased risk of breast cancer such as Peutz-Jegher syndrome (STK11), Cowden (PTEN) and familial diffuse gastric cancer (E-Cadherin)

Notes:

  • HRT for women with no personal history of breast cancer who have a bilateral salpingo-oophorectomy before the natural menopause
    • when women with no personal history of breast cancer have either a BRCA1 or BRCA2 mutation or a family history of breast cancer and they have had a bilateral salpingo-oophorectomy before their natural menopause, offer them:
      • combined HRT if they have a uterus
      • oestrogen-only HRT if they don't have a uterus
      • up until the time they would have expected natural menopause (average age for natural menopause is 51-52 years)
    • manage menopausal symptoms occurring when HRT is stopped in the same way as symptoms of natural menopause

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.